Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia

被引:4
|
作者
Tan, Jian Hong [1 ]
Ahmad Azahari, Ahmad Hazim Syakir [1 ]
Ali, Adli [1 ,2 ]
Ismail, Noor Akmal Shareela [2 ,3 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Paediat, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, UKM Specialist Childrens Hosp, Hosp Tunku Ampuan Besar Tuanku Aishah Rohani, Res Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[3] Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
关键词
autoimmune; epigenetic; blood disorder; DNA methylation; histone modification; lncRNA; miRNA; MESSENGER-RNA EXPRESSION; BLOOD MONONUCLEAR-CELLS; NONCODING RNA; T-CELL; DNA METHYLATION; IFN-GAMMA; HISTONE METHYLATION; BONE-MARROW; IMBALANCE; TH1;
D O I
10.3390/genes14030555
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Immune Thrombocytopenia (ITP) is an autoimmune blood disorder that involves multiple pathways responsible for the homeostasis of the immune system. Numerous pieces of literature have proposed the potential of immune-related genes as diagnostic and prognostic biomarkers, which mostly implicate the role of B cells and T cells in the pathogenesis of ITP. However, a more in-depth understanding is required of how these immune-related genes are regulated. Thus, this scoping review aims to collate evidence and further elucidate each possible epigenetics mechanism in the regulation of immunological pathways pertinent to the pathogenesis of ITP. This encompasses DNA methylation, histone modification, and non-coding RNA. A total of 41 studies were scrutinized to further clarify how each of the epigenetics mechanisms is related to the pathogenesis of ITP. Identifying epigenetics mechanisms will provide a new paradigm that may assist in the diagnosis and treatment of immune thrombocytopenia.
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Recent advances in the mechanisms and treatment of immune thrombocytopenia
    Provan, Drew
    Semple, John W.
    EBIOMEDICINE, 2022, 76
  • [42] Glycosylation of autoantibodies: Insights into the mechanisms of immune thrombocytopenia
    Bakchoul, Tamam
    Walek, Kathrin
    Krautwurst, Annika
    Rummel, Mathias
    Bein, Gregor
    Santoso, Sentot
    Sachs, Ulrich J.
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1259 - 1266
  • [43] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
    Zufferey, Anne
    Kapur, Rick
    Semple, John W.
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (02):
  • [44] Platelet destruction in immune thrombocytopenia Understanding the mechanisms
    Bakchoul, Tamam
    Sachs, Ulrich J.
    HAMOSTASEOLOGIE, 2016, 36 (03): : 187 - 194
  • [45] Thrombocytopenia in intensive care unit patients: A scoping review
    Jonsson, Andreas Bender
    Rygard, Sofie Louise
    Hildebrandt, Thomas
    Perner, Anders
    Moller, Morten Hylander
    Russell, Lene
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2021, 65 (01) : 2 - 14
  • [46] A Review on Secondary Immune Thrombocytopenia in Malaysia
    Zahidin, Muhamad Aidil
    Mohd Noor, Noor Haslina
    Johan, Muhammad Farid
    Abdullah, Abu Dzarr
    Zulkafli, Zefarina
    Edinur, Hisham Atan
    HEALTHCARE, 2022, 10 (01)
  • [47] Romiplostim as a treatment for immune thrombocytopenia: a review
    Chalmers, Sarah
    Tarantino, Michael D.
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 37 - 44
  • [48] Fostamatinib: A Review in Chronic Immune Thrombocytopenia
    Paik, Julia
    DRUGS, 2021, 81 (08) : 935 - 943
  • [49] Immune thrombocytopenia: a review on the pathogenetic role of immune cells
    Nokhostin, Forogh
    Bakhshpour, Fatemeh
    Pezeshki, Seyed Mohammad Sadegh
    Khademi, Reyhane
    Saki, Najmaldin
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (10) : 731 - 742
  • [50] Fostamatinib: A Review in Chronic Immune Thrombocytopenia
    Julia Paik
    Drugs, 2021, 81 : 935 - 943